Hair loss news

Hair loss drug what to trust and choose — line up domestic sales Big 5 at ground level | Korea's No.1 Hair Loss Community, DAEDAMO

대다모 · 2026-06-18T14:26:34+09:00

Five topselling hair loss treatments from Propecia to Pansidil were compared again with the standard of intensity of clinical evidence Even with the same hair loss drug what and how far it was proven differed greatly from product to product As the hair loss market grows dozens of types of hair loss drugs are pouring into pharmacies hospitals and nonfacetoface treatment apps Based on the tally of pharmaceutical market research institutes the domestic hair loss treatment specialized medicine market in 2024 is worth about 188 billion won continuing to grow by double digits every year However it is difficult to determine which drugs have been proven how much by looking at the advertising text alone We lined up the top five products in terms of the design and scale of clinical trials that is the level of evidence the two pillars of the market and the general two mountain ranges The prescription market is divided into two families of 5alpha reductase inhibitors They are the original Pinasteride series Korea Organon Profesia and the original Dutasteride series GSK Avodat On top of that domestic generics such as the new JW drug Monard with prices are rapidly expanding their market share In the overthecounter OTC market Dongkuk Pharmaceuticals Pancidil is the top seller and HYUNDAIPHARMs Mineoxidil Minoxidil is the representative drug These five are in fact the central axis of the domestic hair loss drug market ① Hardest evidence — Propecia 1 mg of finasteride In terms of the thickness of the evidence pinasteride is at its peak A phase 3 study published in the Journal of the American Academy of Dermatology JAAD in 1998 by Kaufman and others conducted a placebocontrolled doubleblind study of 1553 men aged 1841 for one year and many continued until the second year of extended trials Results are statistically significant improvements over placebo in all indicators including hair count patientresearcher evaluation and photo reading P